Direct Lentiviral Injection Gene Therapy for MLD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Direct Lentiviral Injection Gene Therapy for MLD — Stella

Recruiting

Back to Metachromatic Leukodystrophy (MLD) trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Lung-Ji Chang, Shenzhen, Guangdong

Key details

Sponsor

Shenzhen Geno-Immune Medical Institute

Enrollment target

~10 participants

Started

May 2025

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

1 Month – 50 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov